TP53 and enteropathy-associated T-cell lymphoma: With respect to disease subgroups, KRAS and TP53 were identified as drivers in atypical MEITL, JAK1 in EATL with CeD, and HLA-A was close to significance in EATL with no CeD history (q val = 0.019).